APLN and breast cancer: Importantly, NeuT;Apln−/− tumor‐bearing mice displayed a delay in the onset of NeuT‐driven mammary tumors and a significantly prolonged survival compared with NeuT;Apln+/+ littermates (Figs EV1C and 1A).